Skip to main content

Advertisement

SpringerLink
Log in

Intestinal gas

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

The most common symptoms associated with intestinal gas are excessive eructation, flatulence, and abdominal bloating and distention. Unfortunately, few therapies have been shown to be effective in treating these symptoms. Excessive eructation can be treated by decreasing excessive air swallowing. Bloating and gaseous distension can improve in some patients by avoiding foods containing partially digested or absorbed polysaccharides, by taking replacement enzymes (such as alfa-galactosidase or lactase), or by taking antibiotics directed toward altering the colonic flora. Activated charcoal or prokinetic agents (such as tegaserod and metoclopramide) also can be effective options in some patients. For noxious odor associated with flatus, bismuth subsalicylate or the charcoal cushion may improve patients’ symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Rao SS: Belching, bloating, and flatulence. How to help patients who have troublesome abdominal gas. Postgrad Med 1997, 101:263–269; 275–278.

    PubMed  CAS  Google Scholar 

  2. Suarez FL, Levitt MD: An understanding of excessive intestinal gas. Curr Gastroenterol Rep 2000, 2:413–419. A thorough, recent overview of the pathology behind and most effective treatment options for excessive intestinal gas.

    Article  PubMed  CAS  Google Scholar 

  3. Lasser RB, Bond JH, Levitt MD: The role of intestinal gas in functional abdominal pain. N Engl J Med 1975, 293:524–526.

    Article  PubMed  CAS  Google Scholar 

  4. Levitt MD: Volume and composition of human intestinal gas determined by means of an intestinal washout technique. N Engl J Med 1971, 284:1394–1398. A comparison of intestinal gas levels in people with and without bloating, using the argon gas washout technique. The quantity of gas expelled was similar in patients with bloating compared with in normal controls.

    Article  PubMed  CAS  Google Scholar 

  5. Chami TN, Schuster MM, Bohlman ME, et al.: A simple radiologic method to estimate the quantity of bowel gas. Am J Gastroenterol 1991, 86:599–602.

    PubMed  CAS  Google Scholar 

  6. Koide A, Yamaguchi T, Odaka T, et al.: Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol 2000, 95:1735–1741.

    Article  PubMed  CAS  Google Scholar 

  7. Alvarez W: Hysterical type of nongaseous abdominal bloating. Arch Intern Med 1949, 84:217–245.

    CAS  Google Scholar 

  8. Serra J, Azpiroz F, Malagelada JR: Intestinal gas dynamics and tolerance in humans. Gastroenterology 1998, 115:542–550. An examination of intestinal gas tolerance by infusion of gas in the jejunum. There is a high tolerance for intestinal gas, unless the gut transit and evacuation mechanisms fail.

    Article  PubMed  CAS  Google Scholar 

  9. Pimentel M, Chow EJ, Lin HC: Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000, 95:3503–3506. The authors found that 45% of patients referred to their center for bacterial overgrowth had symptoms suggestive of irritable bowel syndrome. Following treatment with oral antibiotics, 48% of patients who normalized their hydrogen breath test for bacterial overgrowth reported improvement in their symptoms of irritable bowel syndrome. In comparison, only 16% of patients who did not normalize their hydrogen breath test had improvement in their symptoms.

    Article  PubMed  CAS  Google Scholar 

  10. Nobaek S, Johansson ML, Molin G, et al.: Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000, 95:1231–1238.

    Article  PubMed  CAS  Google Scholar 

  11. Strocchi A, Levitt MD: Intestinal gas. In Gastrointestinal and Liver Diseases, edn 6. Edited by Feldman M, Sleisenger MH, Scharschmidt BF. Philadelphia: W B Saunders Co; 1998:153–160. This textbook article gives detailed descriptions of the production of intestinal gas in the body.

    Google Scholar 

  12. Suarez F, Levitt MD: Intestinal gas. Clin Perspect Gastroenterol 2000, 3:209–217.

    Google Scholar 

  13. Suarez FL, Furne J, Springfield J, et al.: Failure of activated charcoal to reduce the release of gases produced by the colonic flora. Am J Gastroenterol 1999, 94:208–212.

    Article  PubMed  CAS  Google Scholar 

  14. Potter T, Ellis C, Levitt M: Activated charcoal: in vivo and in vitro studies of effect on gas formation. Gastroenterology 1985, 88:620–624.

    PubMed  CAS  Google Scholar 

  15. Ganiats TG, Norcross WA, Halverson AL, et al.: Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance. J Fam Pract 1994, 39:441–445.

    PubMed  CAS  Google Scholar 

  16. Suarez FL, Springfield J, Levitt MD: Identification of gases responsible for the odour of human flatus and evaluation of a device purported to reduce this odour. Gut 1998, 43:100–104.

    Article  PubMed  CAS  Google Scholar 

  17. Suarez FL, Springfield J, Furne JK, et al.: Gas production in human ingesting a soybean flour derived from beans naturally low in oligosaccharides. Am J Clin Nutr 1999, 69:135–139.

    PubMed  CAS  Google Scholar 

  18. 2000 Drug Topics Red Book. Montvale, NJ: Medical Economics Co; 2000.

  19. Suarez FL, Furne JK, Springfield J, et al.: Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon. Gastroenterology 1998, 114:923–929.

    Article  PubMed  CAS  Google Scholar 

  20. Mauro LS, Nawarskas JJ, Mauro VF: Misadventures with activated charcoal and recommendations for safe use. Ann Pharmacother 1994, 28:915–924.

    PubMed  CAS  Google Scholar 

  21. Johnson AG: Controlled trial of metoclopramide in the treatment of flatulent dyspepsia. BMJ 1971, 2:25–26.

    Article  PubMed  CAS  Google Scholar 

  22. Bell AJ, Ciclitira PJ: Managing bloating, flatus and flatulence. Practitioner 2000, 244:301–304, 306, 308–311.

    PubMed  CAS  Google Scholar 

  23. Di Stefano M, Strocchi A, Malservisi S, et al.: Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms. Aliment Pharmacol Ther 2000, 14:1001–1008.

    Article  PubMed  Google Scholar 

  24. King TS, Elia M, Hunter JO: Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998, 352:1187–1189.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Hospital, 330 Brooklyn Avenue, 02215, Boston, MA, USA

    Rebecca N. Fink BA & Anthony J. Lembo MD

Authors
  1. Rebecca N. Fink BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony J. Lembo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fink, R.N., Lembo, A.J. Intestinal gas. Curr Treat Options Gastro 4, 333–337 (2001). https://doi.org/10.1007/s11938-001-0059-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-001-0059-6

Keywords

Search

Navigation